Michael Miller
15PUBLICATIONS
35CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (15)
Sort by Publication Date:
|Sep 22, 2025
Benefit of Icosapent Ethyl Across Types and Sizes of Myocardial Infarction in REDUCE-IT.Chen Gurevitz, Deepak L Bhatt, Robert P Giugliano
|Feb 19, 2025
Cardiovascular Outcomes With Icosapent Ethyl by Baseline Low-Density Lipoprotein Cholesterol: A Secondary Analysis of the REDUCE-IT Randomized Trial.Rahul Aggarwal, Deepak L Bhatt, Ph Gabriel Steg
|Dec 29, 2023
Cost-Effectiveness of Icosapent Ethyl in REDUCE-IT USA: Results From Patients Randomized in the United States.William S Weintraub, Deepak L Bhatt, Zugui Zhang
|Nov 30, 2023
Effectiveness of icosapent ethyl on first and total cardiovascular events in patients with metabolic syndrome, but without diabetes: REDUCE-IT MetSyn.Michael Miller, Deepak L Bhatt, Eliot A Brinton
|Jul 28, 2023
Fibrates, Hypertriglyceridemia, and CVD Risk: Where Do We Stand After the PROMINENT Trial for Triglyceride Lowering?Marius I Chukwurah, Michael Miller
|Feb 21, 2023
Cardiovascular Benefits of Icosapent Ethyl in Patients With and Without Atrial Fibrillation in REDUCE-IT.Brian Olshansky, Deepak L Bhatt, Michael Miller
Pageof 3
Frequent Collaborators
11 joint publications
Deepak L Bhatt
11 joint publications
Eliot A Brinton
11 joint publications
Jean-Claude Tardif
11 joint publications
Christie M Ballantyne
10 joint publications
Ph Gabriel Steg
7 joint publications
Terry A Jacobson
5 joint publications
Rebecca A Juliano
5 joint publications
Ralph T Doyle
5 joint publications
R Preston Mason
5 joint publications
Lixia Jiao
